Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

Abroad (travel likely)RecruitingPHASE4

Conditions

CMV · Lung Transplant Recipient

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Ilona Bahinskaya, MSc, CCRP) · Ilona.Bahinskaya@uhn.ca · 416-340-4800

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir

Pregnant Women · CMV Infected Fetuses

Abroad (travel likely)RecruitingPHASE3

Paris, France

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Cytomegalovirus Infections · CMV

Abroad (travel likely)Recruiting

Suzhou, China

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

EBV · HSV · VZV

Abroad (travel likely)Recruiting

Bethesda, United States

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

BKV Infection · CMV Infection · EBV Infection

Abroad (travel likely)Recruiting

Seoul, South Korea